AWM
BIIB icon

Altium Wealth Management’s Biogen BIIB Stock Holding History

Altium Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-895
Closed -$254K – 353
2020
Q3 		$254K Sell
895
-43
-5% -$12K 0.03% 289
2020
Q2 		$251K Buy
938
+166
+22% +$49.9K 0.03% 285
2020
Q1 		$244K Buy
+772
New +$234K 0.03% 256
2019
Q2 		– Sell
-1,044
Closed -$247K – 282
2019
Q1 		$247K Sell
1,044
-13
-1% -$4.09K 0.04% 231
2018
Q4 		$318K Buy
1,057
+222
+27% +$70.8K 0.06% 199
2018
Q3 		$295K Buy
+835
New +$287K 0.06% 222

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Altium Wealth Management's BIIB Position: Q4 2020 in Review

Altium Wealth Management sold out of Biogen (BIIB) in Q4 2020, closing a stake of 895 shares — an estimated $254K sold.

Altium Wealth Management first reported a position in BIIB in Q3 2018 and held it in 6 quarters. The position peaked at $318K in Q4 2018. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Altium Wealth Management reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Altium Wealth Management sold 895 Biogen shares in Q4 2020, an estimated $254K.
  • Altium Wealth Management first reported a position in Biogen in Q3 2018 and held it in 6 quarters.
  • Altium Wealth Management's Biogen position peaked at $318K in Q4 2018.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Altium Wealth Management's 13F filing for Q4 2020, filed 4 Feb 2021.